Mangoceuticals, Inc. financial data

Symbol
MGRX on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
15110 Dallas Pkwy, Suite 600, Dallas, Texas
State of incorporation
Texas
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 297 %
Quick Ratio 4.39 %
Debt-to-equity 49.6 %
Return On Equity -864 % -145%
Return On Assets -578 %
Operating Margin -1.07K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.6M shares +47.4%
Common Stock, Shares, Outstanding 23.6M shares +54.2%
Entity Public Float 13.4M USD
Common Stock, Value, Issued 2.36K USD +54.2%
Weighted Average Number of Shares Outstanding, Basic 22.8M shares +103%
Weighted Average Number of Shares Outstanding, Diluted 22.8M shares +103%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 845K USD +113%
Cost of Revenue 152K USD -12.5%
General and Administrative Expense 3.96M USD +126%
Operating Income (Loss) -9.03M USD -99.2%
Nonoperating Income (Expense) 6.47K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.02M USD -98.7%
Net Income (Loss) Attributable to Parent -9.02M USD -98.7%
Earnings Per Share, Basic -0.44 USD/shares -4.76%
Earnings Per Share, Diluted -0.44 USD/shares +56.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.3K USD
Inventory, Net 14.5K USD
Assets, Current 89.8K USD -97.7%
Property, Plant and Equipment, Net 89.9K USD -21.8%
Operating Lease, Right-of-Use Asset 105K USD -34.9%
Assets 301K USD -92.7%
Liabilities, Current 1.21M USD +563%
Operating Lease, Liability, Noncurrent 47.7K USD -57.9%
Liabilities 1.26M USD +325%
Accumulated Other Comprehensive Income (Loss), Net of Tax -70 USD
Retained Earnings (Accumulated Deficit) -13.6M USD -197%
Stockholders' Equity Attributable to Parent -958K USD -125%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -958K USD -125%
Liabilities and Equity 301K USD -92.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -991K USD +45.2%
Net Cash Provided by (Used in) Financing Activities 268K USD -94.7%
Net Cash Provided by (Used in) Investing Activities -3.52K USD +91.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 23.6M shares +54.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 56.1K USD -91.5%
Deferred Tax Assets, Valuation Allowance 11.2M USD +457%
Deferred Tax Assets, Gross 11.2M USD +457%
Operating Lease, Liability 113K USD -34%
Depreciation 6.22K USD +2.34%
Payments to Acquire Property, Plant, and Equipment 3.52K USD -91.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.37M USD +7.55%
Lessee, Operating Lease, Liability, to be Paid 121K USD -41.9%
Operating Lease, Liability, Current 65.6K USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 67.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 67.6K USD -5.76%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.16K USD -78%
Deferred Tax Assets, Operating Loss Carryforwards 9.21M USD
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 12.6M USD +50.5%
Share-based Payment Arrangement, Expense 79.7K USD
Interest Expense 1.76K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares